| 发明名称 |
PHARMACEUTICAL FOR PROPHYLAXIS OR TREATMENT OF HYPERTENSION |
| 摘要 |
A pharmaceutical for the prophylaxis or treatment of hypertension or a disease derived from hypertension. The pharmaceutical is characterized by comprising (i) a specific mineralocorticoid receptor antagonist and (ii) one or more components selected from the following components (A) to (C), for administration simultaneously or separately at a time interval: (A) an angiotensin II receptor antagonist, (B) a calcium antagonist, and (C) a diuretic. |
| 申请公布号 |
US2016206593(A1) |
申请公布日期 |
2016.07.21 |
| 申请号 |
US201614996064 |
申请日期 |
2016.01.14 |
| 申请人 |
Daiichi Sankyo Company, Limited |
发明人 |
Arai Kiyoshi;Homma Tsuyoshi;Mizuno Makoto |
| 分类号 |
A61K31/40;A61K31/549;A61K31/4178;A61K31/4422 |
主分类号 |
A61K31/40 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A pharmaceutical for the prophylaxis or treatment of hypertension or a disease derived from hypertension, characterized by comprising
(i) a mineralocorticoid receptor antagonist which comprises a substance selected from the group consisting of a compound represented by the following formula (I): and an atropisomer thereof, and a pharmacologically acceptable salt thereof, and (ii) one or more components selected from the following components (A) to (C), for administration simultaneously or separately at a time interval:
(A) one or more angiotensin II receptor antagonists;(B) one or more calcium antagonists comprising a substance selected from the group consisting of a 1,4-dihydropyridine-based compound and a pharmacologically acceptable salt thereof; and(C) one or more diuretics. |
| 地址 |
Tokyo JP |
